Total Payments
$7,500
2024 Payments
$2,402
Companies
13
Transactions
358
Payment Breakdown by Category
Food & Beverage$7,428 (99.0%)
Education$71.49 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,428 | 357 | 99.0% |
| Education | $71.49 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,466 | 57 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,167 | 45 | $0 (2024) |
| ABBVIE INC. | $981.09 | 68 | $0 (2024) |
| ITI, Inc. | $958.66 | 40 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $816.41 | 44 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $571.47 | 32 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $355.27 | 13 | $0 (2024) |
| Axsome Therapeutics, Inc. | $300.52 | 11 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $247.30 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $243.86 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,402 | 124 | Teva Pharmaceuticals USA, Inc. ($636.06) |
| 2023 | $2,542 | 135 | ABBVIE INC. ($527.54) |
| 2022 | $2,555 | 99 | ITI, Inc. ($570.33) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 5 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: CNS | ||||||
| 02/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $97.70 | General |
| Category: CNS | ||||||
| 02/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: CNS | ||||||
| 02/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.10 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Central Nervous System | ||||||
| 01/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: PSYCHIATRY | ||||||
| 01/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Neuroscience | ||||||
| 01/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Central Nervous System | ||||||
| 01/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: Central Nervous System | ||||||
| 01/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Neuroscience | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: CNS | ||||||
| 01/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: PSYCHIATRY | ||||||
| 01/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: PSYCHIATRY | ||||||
| 01/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Central Nervous System | ||||||
| 01/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: NEUROSCIENCE | ||||||
About Robert Willett
Robert Willett is a Psychiatric/Mental Health healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2021. The National Provider Identifier (NPI) number assigned to this provider is 1720754096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Willett has received a total of $7,500 in payments from pharmaceutical and medical device companies, with $2,402 received in 2024. These payments were reported across 358 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($7,428).
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Mobile, AL
- Active Since 08/18/2021
- Last Updated 04/03/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1720754096
Products in Payments
- ARISTADA (Drug) $1,243
- CAPLYTA (Drug) $1,206
- VRAYLAR (Drug) $981.09
- INVEGA SUSTENNA (Drug) $668.56
- Austedo XR (Drug) $658.94
- INGREZZA (Drug) $355.27
- AUSTEDO (Drug) $352.49
- REXULTI (Drug) $330.63
- Auvelity (Drug) $300.52
- ABILIFY MAINTENA (Drug) $267.77
- LYBALVI (Drug) $223.82
- COBENFY (Drug) $201.81
- SPRAVATO (Drug) $147.85
- ABILIFY ASIMTUFII (Drug) $127.45
- PERSERIS (Drug) $121.87
- HETLIOZ (Drug) $93.11
- UZEDY (Drug) $84.50
- FANAPT (Drug) $21.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Mobile
Mr. John Hayes, Crnp, CRNP
Psychiatric/Mental Health — Payments: $29,620
Psychiatric/Mental Health $29,620
Mary Lee, Crnp, CRNP
Psychiatric/Mental Health — Payments: $9,297
Psychiatric/Mental Health $9,297
Tammy Lee, Aprn, APRN
Psychiatric/Mental Health — Payments: $8,629
Psychiatric/Mental Health $8,629
Dolores Bray, Crnp, CRNP
Psychiatric/Mental Health — Payments: $7,722
Psychiatric/Mental Health $7,722
Beverly Ales, Crnp, CRNP
Psychiatric/Mental Health — Payments: $5,293
Psychiatric/Mental Health $5,293
Kina Crenshaw
Psychiatric/Mental Health — Payments: $4,673
Psychiatric/Mental Health $4,673